首页> Journal of translational medicine> Immunologic constant of rejection as a predictive biomarker of immune checkpoint inhibitors efficacy in non-small cell lung cancer.

Immunologic constant of rejection as a predictive biomarker of immune checkpoint inhibitors efficacy in non-small cell lung cancer.

导出 OA

翻译打印收藏纠错

第一作者： Alice,Mogenet

第一单位： Multidisciplinary Oncology and Therapeutic Innovations Department, Aix Marseille Univ, APHM, INSERM, CNRS, CRCM, Hôpital Nord, Marseille, France.

作者： Alice,Mogenet ^[1] ; Pascal,Finetti ^[2] ; Emilie,Denicolai ^[2] ; Laurent,Greillier ^[1] ; Pascaline,Boudou-Rouquette ^[3] ; François,Goldwasser ^[3] ; Gwenael,Lumet ^[2] ; Michele,Ceccarelli ^[4] ; Daniel,Birnbaum ^[2] ; Davide,Bedognetti ^[5] ; Emilie,Mamessier ^[2] ; Fabrice,Barlesi ^[6] ; François,Bertucci ^[7] ; Pascale,Tomasini ^[8]

作者单位： Multidisciplinary Oncology and Therapeutic Innovations Department, Aix Marseille Univ, APHM, INSERM, CNRS, CRCM, Hôpital Nord, Marseille, France. ^[1] Centre de Recherche en Cancérologie de Marseille (CRCM), INSERM UMR1068, CNRS UMR725, Laboratoire d'Oncologie Prédictive, Aix Marseille Univ, Marseille, France. ^[2] Department of Medical Oncology, Cochin Hospital, AP-HP, Paris, France-University of Paris Descartes, ARIANE, CARPEM, Paris, France. ^[3] Sylvester Comprehensive Cancer Center, Department of Public Health Sciences, University of Miami Miller School of Medicine, Miami, FL, USA. ^[4] Division of Translational Medicine, Research Branch, Sidra Medicine, Doha, Qatar.;Department of Internal Medicine and Medical Specialties, University of Genoa, Genoa, Italy. ^[5] Paris-Saclay University and Medical Oncology, Gustave Roussy, Cancer Campus, Villejuif, France. ^[6] Centre de Recherche en Cancérologie de Marseille (CRCM), INSERM UMR1068, CNRS UMR725, Laboratoire d'Oncologie Prédictive, Aix Marseille Univ, Marseille, France. bertuccif@ipc.unicancer.fr.;Department of Medical Oncology, Institut Paoli-Calmettes, Aix Marseille Univ, 232, Bd de Sainte-Marguerite, 13009, Marseille, France. bertuccif@ipc.unicancer.fr. ^[7] Multidisciplinary Oncology and Therapeutic Innovations Department, Aix Marseille Univ, APHM, INSERM, CNRS, CRCM, Hôpital Nord, Marseille, France.;Centre de Recherche en Cancérologie de Marseille (CRCM), INSERM UMR1068, CNRS UMR725, Laboratoire d'Oncologie Prédictive, Aix Marseille Univ, Marseille, France. ^[8]

关键词 Biomarkers ICR signature Immune checkpoints inhibitors Immune therapy Lung cancer Transcriptomics

医学主题词人类(Humans);癌, 非小细胞肺(Carcinoma, Non-Small-Cell Lung);回顾性研究(Retrospective Studies);肺肿瘤(Lung Neoplasms)

DOI 10.1186/s12967-023-04463-2

PMID 37726776

发布时间 2023-11-21

翻译满意度评价：

准确一般字义偏差语意偏离译文作用小提交